Isogenis' products will completely change the way transplantation is done today. These technologies stand to improve the quality of life of recipients, improve economic productivity, and significantly reduce the debilitating cost of health care.

These products induce specific immune suppression, produce livelong acceptance of transplants, and are non-toxic. We base these products on the veto effect which occurs when specific T-cells programmed to destroy a transplant are all permanently inhibited.